Research

Cellular

Adverse events from SGLT-2 inhibitors and GLP-1RAs are primarily mild to moderate and tend to subside with treatment adjustment.

Practitioners should monitor for mild to moderate gastrointestinal side effects when prescribing these medications.

StrongSupportsmedium confidence
Although adverse events were reported in a large proportion of patients, primarily gastrointestinal manifestations, the literature reports that these were mild to moderate in severity and tended to subside following treatment adjustment.
Sachin M. Shridharani et al. · Aesthetic Surgery Journal · 2023

Why this rating

Based on the systematic review of sixteen randomized controlled trials.

Source

The Emerging Role of Injectable Weight Loss Medications in Plastic Surgery: A Systematic Review

Sachin M. Shridharani et al. · Aesthetic Surgery Journal · 2023

DOI 10.1093/asj/sjad240

systematic_review · n=10492Cited 8×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →